337 related articles for article (PubMed ID: 12580835)
1. Elevated maternal mid-trimester chorionic gonadotropin > or =4 MoM is associated with fetal cerebral blood flow redistribution.
Hershkovitz R; Erez O; Sheiner E; Landau D; Mankuta D; Mazor M
Acta Obstet Gynecol Scand; 2003 Jan; 82(1):22-7. PubMed ID: 12580835
[TBL] [Abstract][Full Text] [Related]
2. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E
Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497
[TBL] [Abstract][Full Text] [Related]
3. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
[TBL] [Abstract][Full Text] [Related]
4. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein.
Benn PA; Horne D; Briganti S; Rodis JF; Clive JM
Obstet Gynecol; 1996 Feb; 87(2):217-22. PubMed ID: 8559527
[TBL] [Abstract][Full Text] [Related]
5. Increased maternal serum human chorionic gonadotropin concentrations are an independent risk factor for SGA in dichorionic twin gestations.
Hershkovitz R; Bar G; Erez O; Smolin A; Sheiner E; Mishori-Dery A; Mazor M
J Matern Fetal Neonatal Med; 2005 Aug; 18(2):117-22. PubMed ID: 16203597
[TBL] [Abstract][Full Text] [Related]
6. The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications.
Gonen R; Perez R; David M; Dar H; Merksamer R; Sharf M
Obstet Gynecol; 1992 Jul; 80(1):83-6. PubMed ID: 1603504
[TBL] [Abstract][Full Text] [Related]
7. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
[TBL] [Abstract][Full Text] [Related]
8. The relationship between perinatal outcome of singleton pregnancies and isolated highly elevated levels of maternal serum human chorionic gonadotropin at mid-gestation.
Tavor O; Shohat M; Lipitz S
Isr Med Assoc J; 2007 Jul; 9(7):509-12. PubMed ID: 17710780
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
[TBL] [Abstract][Full Text] [Related]
10. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.
Spencer K; Cowans NJ; Avgidou K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214
[TBL] [Abstract][Full Text] [Related]
11. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome.
Spencer K
Prenat Diagn; 2000 Aug; 20(8):652-6. PubMed ID: 10951476
[TBL] [Abstract][Full Text] [Related]
12. Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Feb; 47(2):194-202. PubMed ID: 26094952
[TBL] [Abstract][Full Text] [Related]
13. Unexplained elevated maternal serum beta-HCG concentration and adverse pregnancy outcome.
Ganapathy R; Lamont RF; Bassett P
Prenat Diagn; 2007 Nov; 27(11):995-9. PubMed ID: 17621365
[TBL] [Abstract][Full Text] [Related]
14. Qualitative venous Doppler flow waveform analysis in preterm intrauterine growth-restricted fetuses with ARED flow in the umbilical artery--correlation with short-term outcome.
Schwarze A; Gembruch U; Krapp M; Katalinic A; Germer U; Axt-Fliedner R
Ultrasound Obstet Gynecol; 2005 Jun; 25(6):573-9. PubMed ID: 15912468
[TBL] [Abstract][Full Text] [Related]
15. Elevated midtrimester maternal serum hCG in chromosomally normal pregnancies is associated with preeclampsia and velamentous umbilical cord insertion.
Heinonen S; Ryynänen M; Kirkinen P; Saarikoski S
Am J Perinatol; 1996 Oct; 13(7):437-41. PubMed ID: 8960614
[TBL] [Abstract][Full Text] [Related]
16. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery.
Spencer K; Cowans NJ; Molina F; Kagan KO; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Feb; 31(2):147-52. PubMed ID: 17992705
[TBL] [Abstract][Full Text] [Related]
17. Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome.
Yaron Y; Heifetz S; Ochshorn Y; Lehavi O; Orr-Urtreger A
Prenat Diagn; 2002 Sep; 22(9):778-82. PubMed ID: 12224070
[TBL] [Abstract][Full Text] [Related]
18. Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol after early transvaginal multifetal pregnancy reduction.
Groutz A; Amit A; Yaron Y; Yovel I; Wolman I; Legum C; Lessing JB
Prenat Diagn; 1996 Aug; 16(8):723-7. PubMed ID: 8878282
[TBL] [Abstract][Full Text] [Related]
19. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler.
Spencer K; Yu CK; Cowans NJ; Otigbah C; Nicolaides KH
Prenat Diagn; 2005 Oct; 25(10):949-53. PubMed ID: 16086443
[TBL] [Abstract][Full Text] [Related]
20. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
Jauniaux E; Gulbis B; Tunkel S; Ramsay B; Campbell S; Meuris S
Prenat Diagn; 1996 Dec; 16(12):1129-35. PubMed ID: 8994249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]